Vivo Bio Tech Limited (BOM:511509)
27.08
-0.10 (-0.37%)
At close: May 27, 2026
Vivo Bio Tech Revenue
Vivo Bio Tech had revenue of 135.13M INR in the quarter ending December 31, 2025, with 10.65% growth. This brings the company's revenue in the last twelve months to 514.24M, up 11.45% year-over-year. In the fiscal year ending March 31, 2025, Vivo Bio Tech had annual revenue of 466.73M with 2.69% growth.
Revenue (ttm)
514.24M
Revenue Growth
+11.45%
P/S Ratio
1.17
Revenue / Employee
2.96M
Employees
174
Market Cap
600.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 466.73M | 12.21M | 2.69% |
| Mar 31, 2024 | 454.51M | -67.79M | -12.98% |
| Mar 31, 2023 | 522.30M | 8.39M | 1.63% |
| Mar 31, 2022 | 513.91M | -3.84M | -0.74% |
| Mar 31, 2021 | 517.75M | -35.77M | -6.46% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tulsyan NEC | 8.57B |
| Nexxus Petro Industries | 3.59B |
| Dhanalaxmi Roto Spinners | 2.51B |
| Trident Texofab | 1.23B |
| Aeonx Digital Technology | 523.43M |
| Chiraharit | 464.93M |
| Asston Pharmaceuticals | 244.84M |
| Hiliks Technologies | 156.93M |